In conclusion, the results of this study indicate that FABP2, ANP and ADIPOQ gene variants are associated with metabolic syndrome or its components in Afro-Caribbeans and suggest a cumulative effect of these variants on the risk of metabolic syndrome and hypertriglyceridemia. The gene discussed is ADIPOQ; the disease is hypertriglyceridemia.